Transactions
| Title | Vitamin Research Products |
|---|---|
| Type | AAI Mandates |
| Category | Nutritional Supplements |
| Subcategory | Sell-side Financing |
| Details | Advisory Associates provided business advisory services to Vitamin Research Products and Castanea Partners in Castanea's combined investment in VRP and Health Resources. Castanea Partners will combine the two businesses to create a vertically-integrated platform in the nutritional supplement industry. The consolidated company will have multiple unique brands marketed to distinct and highly loyal consumer segments. |
| Title | I Drive Smart |
|---|---|
| Type | AAI Mandates |
| Category | Small Business |
| Subcategory | Strategic Advisory Services |
| Details | AAI provided strategic operational and financial advisory services to I Drive Smart, a nationally recognized driver’s education school exclusively taught by law enforcement professionals, as the company poises for regional expansion. AAI leveraged deep experience in business process optimization in helping I Drive Smart consolidate local resources as they prepare to branch out. |
| Title | Graceway Pharmaceuticals |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Acquisition and Licensing |
| Details | AAI advised Graceway Pharmaceuticals in their acquisition of Pfizer's dermatological product portfolio. Graceway acquired two molecules for the treatment of acne and a molecule for the treatment of scar formation. Concurrent with the agreement, Pfizer agreed to offer developmental and clinical services for the molecules. |
| Title | Cytorex Biosciences |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Financing |
| Details | AAI advised Cytorex Biosciences, a pre-clinical stage biopharmaceutical company, in its $40 million seed-round financing. Cytorex Biosciences will use the funds to complete development of its leading therapeutic candidate,Cytoreg®, through Phase II trials for the indication of malignant brain tumors. |
| Title | Main Street Resources |
|---|---|
| Type | AAI Mandates |
| Category | Federal Contractor - Design & Manufacturing |
| Subcategory | M&A Buy-Side |
| Details | AAI acted as a buy-side advisor to Main Street Resources in their acquisition of Protective Armored Systems (PAS). Founded in 1993 and headquartered in Lee, MA, PAS is a specialty fabricator of ballistics glass for the government and private sectors. PAS is an expert in glass and polymer lamination, specializing in customized bullet-resistant and security glazing fabrication. Customers include government, law enforcement, architects, business and private individuals. |
| Title | Graceway Pharmaceuticals, LLC |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Equity Financing |
| Details | AAI provided business advisory services in developing the business model that resulted in an equity financing transaction, in the amount of $200 million, involving GTCR Golder Rauner, LLC; a private equity firm that manages more than $8 billion in equity and mezzanine capital invested in a wide range of companies and industries, and Jefferson Gregory, co-founder of King Pharmaceuticals to form Graceway Pharmaceuticals, LLC; a specialty pharmaceutical company that focuses on bringing branded prescription products to the U.S. market through acquisition, in-licensing, and product development. Subsequently, Graceway made its first acquisition by acquiring 3M's branded pharmaceutical business in the U.S., Puerto Rico, Canada and Latin America in a transaction valued at $875 million. |
| Title | Colliers International Property Consultants, Inc. and PharmaBioSource, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Divestiture Sell-Side |
| Details | Advisory Associates acted as advisor to both Colliers International Property Consultants, Inc., a globally affiliation of independently owned commercial real estate firms totaling more than 10,000 employees and spanning the world in more than 260 offices in 57 countries; and PharmaBioSource, Inc., a pharmaceutical and biotechnology capacity, transaction and consulting service company; in a transaction valued at $100 million involving the divestiture of an operating pharmaceutical facility, which included the legacy products manufactured there and the related contract manufacturing business. |
| Title | Citigroup, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Debt Financing |
| Details | Advisory Associates acted as advisor to Citigroup - Global Healthcare Group, a division of Citigroup's Global Capital Markets, in a transaction involving the placement of $400 million in convertible debt for a publicly traded pharmaceutical company. |
| Title | Stellar Pharmaceuticals, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Licensing |
| Details | Advisory Associates served as the exclusive advisor to Stellar Pharmaceuticals, Inc., a company that develops high quality, cost effective proprietary products based on its core polysaccharide technology for niche, under-served markets, in a transaction involving the licensing rights and related supply agreement of its product Uracyst ®, Stellar’s novel agent for the treatment of interstitial cystitis, to Watson Pharmaceuticals, Inc. |
| Title | PreMD, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Licensing |
| Details | Advisory Associates served as the exclusive advisor to PreMD, Inc., a world leader in predictive medicine, in a transaction involving the licensing rights for the U.S. marketing and distribution of its novel non-invasive skin cholesterol test, currently marketed as PREVU - that helps assess an individual’s risk of coronary heart disease, to AstraZeneca Pharmaceuticals LP. |
| Title | PRA International, Inc. and The Emmes Corporation |
|---|---|
| Type | AAI Mandates |
| Category | Healthcare Services |
| Subcategory | Clinical Advisory |
| Details | Advisory Associates provided AAI Mandates services to PRA International, Inc., one of the world’s leading global clinical development organizations with more than 3000 employees worldwide, and The Emmes Corporation, a contract research organization dedicated to providing statistical and epidemiological expertise and other overall operational support services to clients engaged in clinical and biomedical research, in a transaction involving the clinical development of a novel Age related Macular Degeneration (AMD) molecule. |
| Title | Middlebrook Pharmaceuticals, Inc. (formerly Advancis Pharmaceutical, Inc.) and Lehman Brothers, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Biotech |
| Subcategory | Equity Financing |
| Details | Advisory Associates provided AAI Mandates services to Lehman Brothers related to the Initial Public Offering of Advancis, a pharmaceutical company focused on developing and commercializing anti-infective drug products utilizing its proprietary, once-a-day pulsatile drug delivery technology, PULSYS. |
| Title | Leitner Pharmaceuticals, LLC |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Business Advisory Buy-Side |
| Details | Advisory Associates provides ongoing business advisory consulting and strategy assessments to Leitner Pharmaceuticals, LLC, a wholly owned subsidiary of SJ Strategic Investments, related to business development opportunities. |